Amarin Corp Plc (AMRN)

[Meowza]

*sigh* Think of it this way: massively multiplayer ##-dimensional chess without turns.

Domestic constraints for/against generic competition:
Patents
Marketing Exclusivity
Payer Exclusivity
State legislation (generic substitution, step therapy)
Anti-trust legislation
...I'm sure there's more, like formularies or hacky EHR or the utter torment of autopopulating PA boilerplate.

Guidelines are fuzzy at best

Domestic stakeholders:
Amarin (subsuming disparate BOD, management, shareholders, employees)
Regulators (FDA, FTC, States)
Political aspirants
BP
Wall Street
Insurers
Suppliers

I don't see the self emulsifying version being held up by red tape.

duherp